ExpressPoints: Current Status and Future Directions for Immunotherapy in Hepatocellular Carcinoma

Download this short summary slideset of key takeaway points from a live presentation on the current status and future directions for immunotherapy in hepatocellular carcinoma.
Ghassan K. Abou-Alfa, MD, MBA
Program Director
Peter R. Galle, MD, PhD
Bruno Sangro, MD, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 285 KB
Released: October 26, 2020

Acknowledgements

Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
AstraZeneca

Related Content

Patient-reported outcomes from the HIMALAYA study of durvalumab with or without tremelimumab vs sorafenib in unresectable hepatocellular carcinoma, presented at ASCO 2022 and reported by Clinical Care Options (CCO)

Released: June 6, 2022

Experts highlight key studies being presented at the 2022 ASCO Annual Meeting in this commentary from Clinical Care Options (CCO)

Allison Betof Warner, MD, PhD John M. Burke, MD Shaji K. Kumar, MD Christopher H. Lieu, MD Stephen V. Liu, MD Joyce O'Shaughnessy, MD Zofia Piotrowska, MD, MHS Angeles Alvarez Secord, MD, MHSc Rachna Shroff, MD Hussein Tawbi, MD, PhD Eunice S. Wang, MD Released: June 1, 2022

Clinical Care Options (CCO): Experts review key data for gastric, rectal, liver, hepatobiliary tract, and pancreas cancers from the 2022 ASCO Gastrointestinal Cancers Symposium and the ASCO Plenary Series

Manish A. Shah, MD Rachna Shroff, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: April 20, 2022 Expired: April 19, 2023

Experts discuss the use of immunotherapy for HCC in this commentary from Clinical Care Options (CCO)

person default Adam Burgoyne, MD, PhD Lipika Goyal, MD Stacey Stein, MD Released: March 21, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings